Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Arbevel

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 17
Average round size
info
The average size of a deal this fund participated in
$22M
Portfolio companies 14
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.18
Exits 1
Key employees 1

Areas of investment

  • Health Care
  • Medical
  • Medical Device
  • Biotechnology
  • E-Commerce
Summary

The venture was found in Europe in France. The leading representative office of defined Corporate Investor is situated in the Paris.

We can highlight the next thriving fund investment areas, such as Pharmaceutical, Therapeutics. For fund there is a match between the location of its establishment and the land of its numerous investments - France. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight TransCure bioServices, NH TherAguix.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Arbevel, startups are often financed by Venture Kick, EASME - EU Executive Agency for SMEs. The meaningful sponsors for the fund in investment in the same round are Supernova Invest, Omnes Capital, Bpifrance.

The fund is constantly included in 2-6 deals per year. The usual things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2019.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Arbevel:
Typical Co-investors
Arbevel is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Arbevel:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Akilia Partners -
Hefu Ruitai -
Horus Capital China, Qingdao Shi, Shandong
Inmarsat Plc England, London, United Kingdom
Luna -
Maoyan Beijing, Beijing, China
Ningbo Shanshan China, Ningbo, Zhejiang
Santo Venture Capital Bayern, Germany, Holzkirchen
SF Capital Group New York, New York, United States
Torreal Madrid, Madrid, Spain

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

UroMems

Health Care
Medical
Medical Device
$51M25 Jun 2024 Grenoble, Auvergne-Rhône-Alpes, France

MEXBRAIN

Biotechnology
$6M06 May 2021 Rhone-Alpes, Auvergne-Rhône-Alpes, France

UroMems

Health Care
Medical
Medical Device
$8M06 Apr 2021 Grenoble, Auvergne-Rhône-Alpes, France

Adwanted Group

Advertising
Advertising Platforms
Events
Media and Entertainment
News
$17M02 Apr 2021 New York, New York, United States

Corwave

Health Care
Manufacturing
Medical Device
$41M06 Jan 2021 Paris, Ile-de-France, France

keepMED

Health Care
Health Diagnostics
Medical
$15M29 Sep 2020 North District

UroMems

Health Care
Medical
Medical Device
$18M20 May 2020 France, Auvergne-Rhône-Alpes

Scipio Bioscience

Biopharma
Biotechnology
Clinical Trials
$7M25 Feb 2020 Paris, Ile-de-France, France

NH TherAguix

Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
$15M11 Apr 2019 Villeurbanne, Auvergne-Rhône-Alpes

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Arbevel?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 17
Average round size 22M
Peak activity year 2021
Lead investments 4
Follow on index 0.18
Exits 1
Group Appearance index 0.82

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

UroMems

Health Care
Medical
Medical Device
$51M25 Jun 2024 Grenoble, Auvergne-Rhône-Alpes, France

MEXBRAIN

Biotechnology
$6M06 May 2021 Rhone-Alpes, Auvergne-Rhône-Alpes, France

UroMems

Health Care
Medical
Medical Device
$8M06 Apr 2021 Grenoble, Auvergne-Rhône-Alpes, France

Adwanted Group

Advertising
Advertising Platforms
Events
Media and Entertainment
News
$17M02 Apr 2021 New York, New York, United States

Corwave

Health Care
Manufacturing
Medical Device
$41M06 Jan 2021 Paris, Ile-de-France, France

keepMED

Health Care
Health Diagnostics
Medical
$15M29 Sep 2020 North District

UroMems

Health Care
Medical
Medical Device
$18M20 May 2020 France, Auvergne-Rhône-Alpes

Scipio Bioscience

Biopharma
Biotechnology
Clinical Trials
$7M25 Feb 2020 Paris, Ile-de-France, France

NH TherAguix

Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
$15M11 Apr 2019 Villeurbanne, Auvergne-Rhône-Alpes
Crunchbase icon

Content report

The following text will be sent to our editors: